New research: Coronavirus vaccination alone will not fully contain virus
India Accelerator Ties Up with Artha Venture Fund for their Summer 2021 Accelerator program for Early-Stage Startups
Lok Sabha MP, doctor by profession, asks govt not to waste ₹35,000 cr on COVID vaccines
Centre urges states to minimise vaccine wastage
As covid cases rise, govt mulls including all above 45 for vaccines

Passion IT Framework

Study: Intravenous Ketamine Is a Rapid and Robust Treatment for Depression

ByPassionIT News --
2022-01-13

Study results on outcomes of ketamine intravenous therapy (KIT) show that it a rapid and robust treatment for depression, health care technology company Osmind and Public Benefit Corporation, said in a statement.

Study: Intravenous Ketamine Is a Rapid and Robust Treatment for Depression

AI chatbot shows potential as diagnostic partner.

Meet 'Coscientist,' your AI lab partner.

AI & Big Data Expo: Maximising value from real-time data streams.

AI & Big Data Expo: Maximising value from real-time data streams.

Danish AI startup Proemial raises €2 million to democratize cutting edge scientific knowledge

Artificial intelligence act: Council and Parliament strike a deal on the first rules for AI in the world.

Comment

Study: Intravenous Ketamine Is a Rapid and Robust Treatment for Depression

Related News

Comment